Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by syienaon Oct 28, 2016 8:52am

106 Views

Post# 25397236

RE:RE:What's With the Cancellation of the Private Placement?

I spoke with Catherine (Investors Relation) via email and by phone yesterday. I can confirm to what Nob4ever and Shake said.

Like everyone else, yesterday's NR threw me off, and I was able to get a response back from the company within a hour, After speaking with Catherine after work last night, I feel confident with my investment esp with news coming down the pipe.

Strongly encourage people to call/email Catherine if they have any questions, or seek clarity on something.

Good luck!

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects